Microanalyse par émission ionique secondaire, J Microsc, vol.1, pp.395-410, 1962. ,
Sur une nouvelle méthode d'analyse cellulaire utilisant le phénomène d'émission ionique secondaire, Ann Phys Biol Med, vol.42, pp.83-94, 1970. ,
Ion microscopy in biology, Scanning Microsc, vol.8, pp.359-70, 1994. ,
Imaging with Mass Spectrometry, Chemical Reviews, vol.99, issue.10, pp.2977-3005, 1999. ,
DOI : 10.1021/cr980137w
Organic ion imaging of biological tissue with secondary ion mass spectrometry and matrix-assisted laser desorption/ionization, Journal of Mass Spectrometry, vol.10, issue.4, pp.355-69, 2001. ,
DOI : 10.1002/jms.153
Scanning secondary ion analytical microscopy with parallel detection, Biology of the Cell, vol.74, issue.1, pp.43-50, 1992. ,
DOI : 10.1016/0248-4900(92)90007-N
A new high performance SIMS instrument: The Cameca "Nanosims 50, Secondary Ion Mass Spectrometry SIMS IX 1993, pp.254-257 ,
Epidemiology of melanoma, Cancer Treat Res, vol.65, pp.29-56, 1993. ,
DOI : 10.1007/978-1-4615-3080-0_2
Epidemiology of Cutaneous Melanoma in Germany and Worldwide, Skin Pharmacology and Physiology, vol.14, issue.5, pp.280-90, 2001. ,
DOI : 10.1159/000056358
Positron emission tomography for staging and management of malignant melanoma, British Journal of Surgery, vol.31, issue.4, pp.389-96, 2002. ,
DOI : 10.1046/j.0007-1323.2002.02059.x
Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma, J Nucl Med, vol.32, pp.1573-80, 1991. ,
An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma, Nuclear Medicine and Biology, vol.20, issue.1, pp.75-84, 1993. ,
DOI : 10.1016/0969-8051(93)90138-K
Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.5, pp.494-502, 1999. ,
DOI : 10.1007/s002590050416
Synthesis, characterization and comparative biodistribution study of a new series of p-Iodine-125 benzamides as potential melanoma imaging agents, Nuclear Medicine and Biology, vol.28, issue.7, pp.799-808, 2001. ,
DOI : 10.1016/S0969-8051(01)00242-6
Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent, Melanoma Research, vol.12, issue.2, pp.115-136, 2002. ,
DOI : 10.1097/00008390-200204000-00003
123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.11, pp.1478-84, 2002. ,
DOI : 10.1007/s00259-002-0971-6
Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy, Cell Mol Biol, vol.47, pp.529-563, 2001. ,
A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoe- thyl)4-iodobenzamide, J Nucl Med, vol.34, pp.2169-75, 1993. ,
Labelled sigma receptor ligands: can their role in neurology and oncology be extended?, European Journal of Nuclear Medicine, vol.38, issue.2, pp.133-138, 2001. ,
DOI : 10.1007/s002590000368